Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2025)

Updated

Zhengye Biotechnology Holding (ZYBT) recorded Enterprise Value of $55.2 million in the quarter ended Dec 31, 2025.

Analysis

Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2025) Analysis & Trends

For the year ended Dec 31, 2025, Zhengye Biotechnology Holding reported Enterprise Value of $55.41 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Zhengye Biotechnology Holding 69.19 Mn 65.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 55.21 Mn
Jun 30, 2025 281.76 Mn
API Access

Zhengye Biotechnology Holding Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZYBT&period=max&api_key=YOUR_API_KEY